Document is current
Any future updates will be listed below
-
Authors
Muhundan, Mathula
Dash, Satya https://orcid.org/0000-0002-5167-2099
- License Information
-
More Information
Article History
Received: 19 November 2025
Accepted: 7 January 2026
First Online: 2 February 2026
Declarations
:
: Mathula Muhundan declares that she has no competing interests. Satya Dash has received speaker and advisory fees from Novo Nordisk and Eli Lilly.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
